Solid Tumors
Showing 76 - 100 of 598
Solid Tumors Trial run by the National Cancer Institute (NCI) (Nilotinib + Paclitaxel)
Recruiting
- Solid Tumors
- Nilotinib + Paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Samples From People With Unanticipated Response, Significant
Enrolling by invitation
- Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)
Not yet recruiting
- Pancreatic Neoplasms
- +2 more
- BI 907828
- (no location specified)
Aug 22, 2022
Solid Tumors Trial in Worldwide (Regorafenib, (Stivarga, BAY73-4506), Nivolumab (Opdivo))
Active, not recruiting
- Solid Tumors
- Regorafenib, (Stivarga, BAY73-4506)
- Nivolumab (Opdivo)
-
Duarte, California
- +33 more
Aug 18, 2022
Solid Tumors Trial in United States (Proton Therapy, Photon Therapy, SRS, Brachytherapy)
Recruiting
- Solid Tumors
- Proton Therapy, Photon Therapy, SRS, Brachytherapy
-
Birmingham, Alabama
- +18 more
Aug 16, 2022
Tumors, Solid Tumors Trial run by the NCI (TdCyd)
Suspended
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 6, 2022
Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))
Not yet recruiting
- Solid Tumors
- +4 more
- JAB-2485 (Aurora A inhibitor)
- (no location specified)
Aug 4, 2022
Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)
Active, not recruiting
- Metastatic Cancer
- +9 more
-
Mobile, Alabama
- +19 more
Aug 1, 2022
Solid Tumors Trial in France, United States (MEDI9253, Durvalumab)
Recruiting
- Solid Tumors
- MEDI9253
- Durvalumab
-
La Jolla, California
- +19 more
Jul 28, 2022
Solid Tumors, Spine Metastasis Trial in Lyon, Saint-Étienne (Kyphoplasty, Conventional vertebroplasty)
Terminated
- Solid Tumors
- Spine Metastasis
- Kyphoplasty
- Conventional vertebroplasty
-
Lyon, France
- +1 more
Jul 26, 2022
Solid Tumors Trial in Japan (Farletuzumab Ecteribulin)
Active, not recruiting
- Solid Tumors
- Farletuzumab Ecteribulin
-
Matsuyama City, Ehime, Japan
- +9 more
Jul 21, 2022
Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)
Completed
- Metastatic Breast Cancer
- Solid Tumors
-
Aurora, ColoradoUniversity of Colorado Cancer Center
May 17, 2022
Mobile Sensor Technologies to Assess General Symptomology of
Enrolling by invitation
- Neoplasms
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)
Completed
- Neoplasm
- Solid Tumors
-
Camperdown, New South Wales, Australia
- +1 more
Jul 18, 2022
Metastatic Cancer, Solid Tumors Trial run by the NCI (SX-682, M7824, MVA-BN-CV301)
Active, not recruiting
- Metastatic Cancer
- Solid Tumors
- SX-682
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 11, 2022
Solid Tumors, NSCLC, Renal Cell Carcinoma Trial in China (Lenvatinib + Envafolimab, Sunitinib)
Recruiting
- Solid Tumors
- +3 more
- Lenvatinib + Envafolimab
- Sunitinib
-
Benbu, Anhui, China
- +22 more
Jun 28, 2022